DrugPatentWatch Database Preview
Dow Pharm Company Profile
» See Plans and Pricing
What is the competitive landscape for DOW PHARM, and when can generic versions of DOW PHARM drugs launch?
DOW PHARM has nine approved drugs.
There are two US patents protecting DOW PHARM drugs.
There are thirty-one patent family members on DOW PHARM drugs in twenty-two countries and nineteen supplementary protection certificates in fourteen countries.
Summary for Dow Pharm
International Patents: | 31 |
US Patents: | 2 |
Tradenames: | 7 |
Ingredients: | 7 |
NDAs: | 9 |
Patent Litigation for Dow Pharm: | See patent lawsuits for Dow Pharm |
Drugs and US Patents for Dow Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
Dow Pharm | QUIDE | piperacetazine | TABLET;ORAL | 013615-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Dow Pharm | NEO-POLYCIN | gramicidin; neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 060427-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Dow Pharm | NUTRACORT | hydrocortisone | LOTION;TOPICAL | 087644-001 | Aug 24, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Dow Pharm | DOW-ISONIAZID | isoniazid | TABLET;ORAL | 080330-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Dow Pharm | SANSAC | erythromycin | SOLUTION;TOPICAL | 062522-001 | Jan 24, 1985 | DISCN | No | No | Start Trial | Start Trial | |||||
Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dow Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | 5,670,547 | Start Trial |
Dow Pharm | ALTRENO | tretinoin | LOTION;TOPICAL | 209353-001 | Aug 23, 2018 | 6,517,847 | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dow Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Cyprus | 1109189 | Start Trial |
European Patent Office | 2052714 | Start Trial |
Poland | 360589 | Start Trial |
South Korea | 100840169 | Start Trial |
Argentina | 114730 | Start Trial |
China | 1460013 | Start Trial |
Canada | 2417646 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dow Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | 474 | Finland | Start Trial | |
0617614 | SPC/GB01/014 | United Kingdom | Start Trial | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
1304992 | C01304992/01 | Switzerland | Start Trial | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
0617614 | 11/2001 | Austria | Start Trial | PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011 |
1304992 | CR 2013 00053 | Denmark | Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
1304992 | 1390049-3 | Sweden | Start Trial | PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322 |
1304992 | 2013/044 | Ireland | Start Trial | PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.